- ASSISTANT PROFESSOR | Neurosurgery
- ASSISTANT PROFESSOR | Neurology
- ASSISTANT PROFESSOR | Radiology
- Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Mount Sinai St. Luke's and Mount Sinai West
- Klingenstein Clinical Center, 1-North 212-241-2763212-241-2763
Dr. Paul Singh, MD, MPH is an Assistant Professor of Neurosurgery, Neurology, and Radiology in the Mount Sinai Health System specializing in the endovascular and minimally invasive treatment of different forms of stroke, aneurysms, arteriovenous malformations, dural arteriovenous fistulas, cavernous malformations, and other vascular diseases of the brain and spine. Dr. Singh was previously an Assistant Professor at Rutgers University New Jersey Medical School where he was Co-Director of the Comprehensive Stroke Center, Fellowship Director of Vascular Neurology, and Co-Director of the Primary Stroke Center at Newark Beth Israel Medical Center.
Dr. Singh obtained a Bachelor’s degree with a double major in Biology and Chemistry and completed research in Neurosciences at the College of William and Mary in Williamsburg, Virginia. He completed his medical degree at the Medical College of Virginia in addition to a Masters in Public Health at George Washington University. He finished his residency at Georgetown University Hospital in Neurology and was the Chief Resident at both Georgetown Hospital and the Veteran’s Administration Hospital in Washington, DC. Dr. Singh subsequently completed a Vascular Neurology fellowship at Stanford Hospital in Palo Alto, California where he stayed on faculty for a year specializing in Vascular Neurology at Stanford Hospital. While on faculty at Stanford, Dr. Singh was awarded the Teaching Attending of the Year. He then completed a second fellowship in Neuroendovascular Surgery at Weill Cornell Medical Center in New York City. He has a Subspecialty Certification in Neuroendovascular Surgery granted by The Society of Neurological Surgeons Committee on Advanced Subspecialty Training.
Dr. Singh is dual boarded in Neurology and Vascular Neurology which allows him to bring a unique niche in diagnosing a variety of vascular diseases of the brain and spine including strokes, aneurysms, AVMs, and tumors. His subspecialty training in Neuroendovascular Surgery gives him the ability to use cutting edge technology to treat these conditions using a minimally invasive approach. He also participates in clinical research trials in stroke providing patients the opportunity to participate in new therapies. Dr. Singh has authored several peer-reviewed publications and multiple book chapters.
Neurology, American Board of Psychiatry and Neurology
- Aneurysm Coiling
- Arterial and Venous Disease
- Arteriovenous Malformation of the Brain
- Arteriovenous Malformations
- Balloon Test Occlusion
- Brain Aneurysm
- Carotid Artery Stenosis
- Carotid Stenting
- Cerebral Vasospasm
- Dural Arteriovenous Fistula (DAVF)
- Endovascular Embolization
- Idiopathic Intracranial Hypertension
- Intracerebral Hemorrhage (ICH)
- Mechanical Thrombectomy
- Microvascular Occlusion
- Pediatric Interventions
- Spinal Vascular Malformations
- Subarachnoid Hemorrhage
- Transient Ischemic Attack
- Vascular Malformations
- Venous Sampling
- Venous Sinus Thrombosis
- Venous Thrombosis
MD, Medical College of Virginia
Internship, Internal Medicine
Washington Hospital Center
Georgetown University Hospital
Fellowship, Vascular Neurology
Stanford University Hospital
Cornell University Medical College
Emergency Carotid Artery Stenting in Acute Stroke. Stanford University Medical Center - NeuroInterventional Radiology with Dr. Michael Marks.
"Variability in Brain Regulation of Photoresponsiveness.” Research on Circadian Rhythms in F344 and HSD rats used in proposal for National Institutes of Health–Academic Research Enhancement Award.
Clinical predictors of good outcome in acute ischemic stroke patients undergoing intra-arterial therapies. NIH-NINDS with Dr. Stephen Warach and Dr. Amie Hsia.
Permissive hypertension in establishing collateral blood supply in intracranial stenosis with Dr. Jessy Walia and Dr. Anusha Boyanpolly
The Use of 24 hour head CT after IV tPA with Dr. Miguel Melo Bicchi
Al-Mufti F, Amuluru K, El-Ghanem M, Changa AR, Singh IP, Gandhi CD, Prestigiacomo CJ. Spontaneous Bilateral Carotid-Cavernous Fistulas Secondary to Cavernous Sinus Thrombosis. Neurosurgery 2017 Apr; 80(4).
Mitchell LA, Santarelli JG, Singh IP, Do HM. Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section. Journal of neurointerventional surgery 2014 Jan; 6(1).
Amuluru K, Al-Mufti F, Hannaford S, Singh IP, Prestigiacomo CJ, Gandhi CD. Symptomatic Infratentorial Thrombosed Developmental Venous Anomaly: Case Report and Review of the Literature. Interventional neurology 2016 Mar; 4(3-4).
Al-Mufti F, Amuluru K, Singh IP, Gandhi C, Prestigiacomo CJ. Pipeline embolization device deployment via an envoy distal access XB guiding catheter-biaxial platform: A technical note. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 2016 Apr; 22(2).
Amuluru K, Al-Mufti F, Singh IP, Prestigiacomo C, Gandhi C. Flow Diverters for Treatment of Intracranial Aneurysms: Technical and Clinical Updates. World neurosurgery 2016 Jan; 85.
Amuluru K, Al-Mufti F, Singh IP, Frohman LP, Gandhi CD, Liu JK. Reversal of Visual Impairment Associated with Vasospasm After Resection of Sphenoclinoidocavernous Meningioma with Intra-Arterial Verapamil. World neurosurgery 2016 Aug; 92.
Mitchell LA, Santarelli JG, Singh IP, Do HM. Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section. BMJ case reports 2013 Jan; 2013.
Asrani SG, Singh IP. Three-dimensional nature of retinal nerve fiber layer defects. Journal of glaucoma 2010 Dec; 19(9).
El-Ghanem M, Al-Mufti F, Thulasi V, Singh IP, Gandhi C. Expanding the treatment window for ischemic stroke through the application of novel system-based technology. Neurosurgical focus 2017 Apr; 42(4).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Singh has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.